AJC Editor's Consensus: Psoriasis and Coronary Artery Disease

Vincent E. Friedewald; Jennifer C. Cather; Joel M. Gelfand; Kenneth B. Gordon; Gary H. Gibbons; Scott M Grundy; Michael T. Jarratt; James G. Krueger; Paul M. Ridker; Neil Stone; William C. Roberts

doi:10.1016/j.amjcard.2008.10.004

AJC Editor's Consensus: Psoriasis and Coronary Artery Disease

Vincent E. Friedewald, Jennifer C. Cather, Joel M. Gelfand, Kenneth B. Gordon, Gary H. Gibbons, Scott M Grundy, Michael T. Jarratt, James G. Krueger, Paul M. Ridker, Neil Stone, William C. Roberts

Research output: Contribution to journal › Comment/debate › peer-review

141 Scopus citations

Original language	English (US)
Pages (from-to)	1631-1643
Number of pages	13
Journal	American Journal of Cardiology
Volume	102
Issue number	12
DOIs	https://doi.org/10.1016/j.amjcard.2008.10.004
State	Published - Dec 15 2008

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.amjcard.2008.10.004

Cite this

@article{629d47a5e16b4d7a839628cf3934c6e7,

title = "AJC Editor's Consensus: Psoriasis and Coronary Artery Disease",

author = "Friedewald, {Vincent E.} and Cather, {Jennifer C.} and Gelfand, {Joel M.} and Gordon, {Kenneth B.} and Gibbons, {Gary H.} and Grundy, {Scott M} and Jarratt, {Michael T.} and Krueger, {James G.} and Ridker, {Paul M.} and Neil Stone and Roberts, {William C.}",

note = "Funding Information: This CME activity is supported by an educational grant from Amgen, Thousand Oaks, California. Funding Information: Dr. Friedewald has received honoraria for speaking from Novartis, East Hanover, New Jersey. Dr. Cather has received honoraria for speaking, consulting, and board membership from Amgen; Abbott Laboratories, Abbott Park, Illinois; Astellas, Tokyo, Japan; and Genentech, South San Francisco, California. Dr. Gelfand has received consulting fees from Amgen; Genentech; Pfizer, New York, New York; Celgene, Summit, New Jersey; and Centocor, Horsham, Pennsylvania. Dr. Gelfand is a grants investigator for Amgen, Centocor, and Pfizer. Dr. Gordon has received honoraria for consulting and research grants from Abbott and Centocor and honoraria for consulting from Amgen. Dr. Gibbons has received honoraria for speaking from Merck, Whitehouse Station, New Jersey; and Novartis. Dr. Grundy is a consultant for Merck; Merck/Schering-Plough, Kenilworth, New Jersey; Kos, Abbott Park, Illinois; Pfizer; Eli Lilly, Indianapolis, Indiana; GlaxoSmithKline, Research Triangle Park, North Carolina; Abbott Laboratories; Fournier, Chen{\^o}ve, France; Bristol-Myers Squibb, Plainsboro, New Jersey; Sankyo, Santa Clara, California; AstraZeneca, Wilmington, Delaware; and Sanofi-Aventis, Bridgewater, New Jersey. Dr. Grundy is a research grants investigator for Merck, Abbott, and Kos. Dr. Jarratt is a research grants investigator for Abbott, Amgen, and Genentech. Dr. Krueger has no relevant financial relationships to disclose. Dr. Ridker has received investigator-initiated research grants from the National Heart, Lung, and Blood Institute, Bethesda, Maryland; the National Cancer Institute, Bethesda, Maryland; AstraZeneca; Novartis; Merck; Sanofi-Aventis; the Donald W. Reynolds Foundation, Las Vegas, Nevada; and the Leducq Foundation, Paris, France. Dr. Ridker is a consultant for AstraZeneca; Merck/Schering-Plough; Dade Behring, Deerfield, Illinois; and Isis Pharmaceuticals, Carlsbad, California. Dr Ridker is listed as a co-inventor on patents held by the Brigham and Women's Hospital, Boston, Massachusetts, that relate to the use of inflammatory biomarkers in the detection and treatment of cardiovascular disease. Dr. Stone is a consultant for Abbott; Merck; Schering-Plough; and Unilever, Rotterdam, The Netherlands (donated to American Heart Association). Dr. Stone has received honoraria for educational activities from Abbott, Merck, Pfizer, and Unilever. Dr. Roberts has received honoraria for speaking from Merck/Schering-Plough, AstraZeneca, and Novartis. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",

year = "2008",

month = dec,

day = "15",

doi = "10.1016/j.amjcard.2008.10.004",

language = "English (US)",

volume = "102",

pages = "1631--1643",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "12",

}

TY - JOUR

T1 - AJC Editor's Consensus

T2 - Psoriasis and Coronary Artery Disease

AU - Friedewald, Vincent E.

AU - Cather, Jennifer C.

AU - Gelfand, Joel M.

AU - Gordon, Kenneth B.

AU - Gibbons, Gary H.

AU - Grundy, Scott M

AU - Jarratt, Michael T.

AU - Krueger, James G.

AU - Ridker, Paul M.

AU - Stone, Neil

AU - Roberts, William C.

N1 - Funding Information: This CME activity is supported by an educational grant from Amgen, Thousand Oaks, California. Funding Information: Dr. Friedewald has received honoraria for speaking from Novartis, East Hanover, New Jersey. Dr. Cather has received honoraria for speaking, consulting, and board membership from Amgen; Abbott Laboratories, Abbott Park, Illinois; Astellas, Tokyo, Japan; and Genentech, South San Francisco, California. Dr. Gelfand has received consulting fees from Amgen; Genentech; Pfizer, New York, New York; Celgene, Summit, New Jersey; and Centocor, Horsham, Pennsylvania. Dr. Gelfand is a grants investigator for Amgen, Centocor, and Pfizer. Dr. Gordon has received honoraria for consulting and research grants from Abbott and Centocor and honoraria for consulting from Amgen. Dr. Gibbons has received honoraria for speaking from Merck, Whitehouse Station, New Jersey; and Novartis. Dr. Grundy is a consultant for Merck; Merck/Schering-Plough, Kenilworth, New Jersey; Kos, Abbott Park, Illinois; Pfizer; Eli Lilly, Indianapolis, Indiana; GlaxoSmithKline, Research Triangle Park, North Carolina; Abbott Laboratories; Fournier, Chenôve, France; Bristol-Myers Squibb, Plainsboro, New Jersey; Sankyo, Santa Clara, California; AstraZeneca, Wilmington, Delaware; and Sanofi-Aventis, Bridgewater, New Jersey. Dr. Grundy is a research grants investigator for Merck, Abbott, and Kos. Dr. Jarratt is a research grants investigator for Abbott, Amgen, and Genentech. Dr. Krueger has no relevant financial relationships to disclose. Dr. Ridker has received investigator-initiated research grants from the National Heart, Lung, and Blood Institute, Bethesda, Maryland; the National Cancer Institute, Bethesda, Maryland; AstraZeneca; Novartis; Merck; Sanofi-Aventis; the Donald W. Reynolds Foundation, Las Vegas, Nevada; and the Leducq Foundation, Paris, France. Dr. Ridker is a consultant for AstraZeneca; Merck/Schering-Plough; Dade Behring, Deerfield, Illinois; and Isis Pharmaceuticals, Carlsbad, California. Dr Ridker is listed as a co-inventor on patents held by the Brigham and Women's Hospital, Boston, Massachusetts, that relate to the use of inflammatory biomarkers in the detection and treatment of cardiovascular disease. Dr. Stone is a consultant for Abbott; Merck; Schering-Plough; and Unilever, Rotterdam, The Netherlands (donated to American Heart Association). Dr. Stone has received honoraria for educational activities from Abbott, Merck, Pfizer, and Unilever. Dr. Roberts has received honoraria for speaking from Merck/Schering-Plough, AstraZeneca, and Novartis. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.

PY - 2008/12/15

Y1 - 2008/12/15

UR - http://www.scopus.com/inward/record.url?scp=58149477214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149477214&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2008.10.004

DO - 10.1016/j.amjcard.2008.10.004

M3 - Comment/debate

C2 - 19064017

AN - SCOPUS:58149477214

VL - 102

SP - 1631

EP - 1643

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 12

ER -

AJC Editor's Consensus: Psoriasis and Coronary Artery Disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this